| Efficacy of fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis D Xu, VL Chen, CA Steiner, JA Berinstein, S Eswaran, AK Waljee, ... Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019 | 198 | 2019 |
| Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study JA Berinstein, JL Sheehan, M Dias, EM Berinstein, CA Steiner, ... Clinical Gastroenterology and Hepatology 19 (10), 2112-2120. e1, 2021 | 97 | 2021 |
| Efficacy of induction therapy with high-intensity tofacitinib in 4 patients with acute severe ulcerative colitis JA Berinstein, CA Steiner, RE Regal, JI Allen, JAR Kinnucan, RW Stidham, ... Clinical Gastroenterology and Hepatology 17 (5), 988-990. e1, 2019 | 97 | 2019 |
| Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer … AK Waljee, PDR Higgins, CB Jensen, M Villumsen, SA Cohen-Mekelburg, ... The Lancet Gastroenterology & Hepatology 5 (3), 276-284, 2020 | 61 | 2020 |
| Hepatic steatosis is associated with increased disease severity and liver injury in coronavirus disease-19 VL Chen, F Hawa, JA Berinstein, CA Reddy, I Kassab, KD Platt, CY Hsu, ... Digestive diseases and sciences 66, 3192-3198, 2021 | 44 | 2021 |
| Biomarkers for the prediction and diagnosis of fibrostenosing Crohn’s disease: a systematic review CA Steiner, JA Berinstein, J Louissaint, PDR Higgins, JR Spence, ... Clinical Gastroenterology and Hepatology 20 (4), 817-846. e10, 2022 | 35 | 2022 |
| AXL is a potential target for the treatment of intestinal fibrosis CA Steiner, ES Rodansky, LA Johnson, JA Berinstein, KC Cushing, ... Inflammatory bowel diseases 27 (3), 303-316, 2021 | 32 | 2021 |
| Use of accelerated induction strategy of infliximab for ulcerative colitis in hospitalized patients at a tertiary care center SM Govani, JA Berinstein, AK Waljee, RW Stidham, PDR Higgins, ... Digestive Diseases and Sciences 65, 1800-1805, 2020 | 28 | 2020 |
| Association of variably expressed KIR3dl1 alleles with psoriatic disease J Berinstein, R Pollock, F Pellett, A Thavaneswaran, V Chandran, ... Clinical rheumatology 36, 2261-2266, 2017 | 19 | 2017 |
| Efficacy and safety of dual targeted therapy for partially or non-responsive inflammatory bowel disease: a systematic review of the literature EM Berinstein, JL Sheehan, J Jacob, CA Steiner, RW Stidham, ... Digestive Diseases and Sciences 68 (6), 2604-2623, 2023 | 14 | 2023 |
| The association between nonsteroidal anti-inflammatory drug use and inflammatory bowel disease exacerbations: a true association or residual bias? S Cohen-Mekelburg, T Van, B Wallace, J Berinstein, X Yu, J Lewis, J Hou, ... Official journal of the American College of Gastroenterology| ACG 117 (11 …, 2022 | 14 | 2022 |
| A care coordination intervention improves symptoms but not charges in high-risk patients with inflammatory bowel disease JA Berinstein, SA Cohen-Mekelburg, GM Greenberg, D Wray, SK Berry, ... Clinical Gastroenterology and Hepatology 20 (5), 1029-1038. e9, 2022 | 11 | 2022 |
| The relationship between opioid use and healthcare utilization in patients with inflammatory bowel disease: a systematic review and meta-analysis JL Sheehan, J Jacob, EM Berinstein, LV Greene-Higgs, CA Steiner, ... Inflammatory bowel diseases 28 (12), 1904-1914, 2022 | 9 | 2022 |
| Variations in health care utilization patterns among inflammatory bowel disease patients at risk for high medical service utilization enrolled in high deductible health plans JA Berinstein, SA Cohen-Mekelburg, CA Steiner, M McLeod, M Noureldin, ... Inflammatory Bowel Diseases 27 (6), 771-778, 2021 | 9 | 2021 |
| Therapeutic cancer vaccines NL Berinstein, JA Berinstein Vaccines, 1018-1031, 2013 | 8 | 2013 |
| In-hospital management of inflammatory bowel disease JA Berinstein, D Aintabi, PDR Higgins Current Opinion in Gastroenterology 39 (4), 274-286, 2023 | 6 | 2023 |
| Effectiveness of Upadacitinib for Patients with Acute Severe Ulcerative Colitis: A Multi-Center Experience JA Berinstein, T Karl, A Patel, M Dolinger, TA Barrett, W Ahmed, B Click, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 6 | 2022 |
| Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series J Levine, J McKibbin, R Ham, S Cohen-Mekelburg, S Bishu, K Tang, ... Inflammatory Bowel Diseases, izad279, 2023 | 5 | 2023 |
| Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives JL Sheehan, LV Greene-Higgs, L Swanson, PDR Higgins, SL Krein, ... Clinical and Translational Gastroenterology 14 (6), e00577, 2023 | 5 | 2023 |
| S1111 Non-Alcoholic Fatty Liver Disease Is Associated With Increased Disease Severity in Patients With COVID-19 CA Steiner, JA Berinstein, CY Hsu, J Louissaint, KD Platt, CA Reddy, ... Official journal of the American College of Gastroenterology| ACG 115, S560, 2020 | 4 | 2020 |
Peter D.R. HigginsProfessor of Gastroenterology, Internal Medicine, University of Michigan在 umich.edu 的电子邮件经过验证
